Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_assertion type Assertion NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_head.
- NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_assertion description "[GCKR-L446 carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia, which suggests a potential molecular mechanism by which these two components of the metabolic syndrome can be dissociated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_provenance.
- NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_assertion evidence source_evidence_literature NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_provenance.
- NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_assertion SIO_000772 18556336 NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_provenance.
- NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_assertion wasDerivedFrom befree-20150227 NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_provenance.
- NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_assertion wasGeneratedBy ECO_0000203 NP861610.RASILE4-3F13R2M1FP_zpkjamLh1CehOhTPtldVOcC4Go130_provenance.